110 related articles for article (PubMed ID: 2645037)
1. Expression of tachykinins by ileal and lung carcinoid tumors assessed by combined in situ hybridization, immunocytochemistry, and radioimmunoassay.
Bishop AE; Hamid QA; Adams C; Bretherton-Watt D; Jones PM; Denny P; Stamp GW; Hurt RL; Grimelius L; Harmar AJ
Cancer; 1989 Mar; 63(6):1129-37. PubMed ID: 2645037
[TBL] [Abstract][Full Text] [Related]
2. Immunoreactive tachykinins in 24-h collections of urine from patients with carcinoid tumours: characterization and correlation with plasma concentrations.
Bergstrom M; Theodorsson E; Norheim I; Oberg K
Scand J Clin Lab Invest; 1995 Dec; 55(8):679-89. PubMed ID: 8903838
[TBL] [Abstract][Full Text] [Related]
3. Isolation and characterization of substance P, substance P 5-11, and substance K from two metastatic ileal carcinoids.
Roth KA; Makk G; Beck O; Faull K; Tatemoto K; Evans CJ; Barchas JD
Regul Pept; 1985 Nov; 12(3):185-99. PubMed ID: 2417286
[TBL] [Abstract][Full Text] [Related]
4. Isolation and characterization of neurokinin A, neurokinin A(3-10) and neurokinin A(4-10) from a neutral water extract of a metastatic ileal carcinoid tumour.
Theodorsson-Norheim E; Jörnvall H; Andersson M; Norheim I; Oberg K; Jacobsson G
Eur J Biochem; 1987 Aug; 166(3):693-7. PubMed ID: 3038549
[TBL] [Abstract][Full Text] [Related]
5. Pancreastatin-like immunoreactivity in human carcinoid disease.
McGrath-Linden SJ; Johnston CF; O'Connor DT; Shaw C; Buchanan KD
Regul Pept; 1991 Mar; 33(1):55-70. PubMed ID: 2047545
[TBL] [Abstract][Full Text] [Related]
6. Localization of the tachykinin neurokinin B precursor peptide in rat brain by immunocytochemistry and in situ hybridization.
Lucas LR; Hurley DL; Krause JE; Harlan RE
Neuroscience; 1992 Nov; 51(2):317-45. PubMed ID: 1465196
[TBL] [Abstract][Full Text] [Related]
7. Effect of a long-acting somatostatin analogue (octreotide) on circulating tachykinins and the pentagastrin-induced carcinoid flush.
Balks HJ; Conlon JM; Creutzfeldt W; Stöckmann F
Eur J Clin Pharmacol; 1989; 36(2):133-7. PubMed ID: 2470592
[TBL] [Abstract][Full Text] [Related]
8. Tachykinin production by carcinoid tumours in culture.
Norheim I; Wilander E; Oberg K; Theodorsson-Norheim E; Lundqvist ML; Lindgren P; Bergh J
Eur J Cancer Clin Oncol; 1987 Jun; 23(6):689-95. PubMed ID: 3477459
[TBL] [Abstract][Full Text] [Related]
9. Cytometric study of carcinoid tumors and their metastases.
Olinici CD; Cäluser I
Arch Geschwulstforsch; 1988; 58(6):403-9. PubMed ID: 3223791
[TBL] [Abstract][Full Text] [Related]
10. Increased intestinal non-substance P tachykinin concentrations in malignant midgut carcinoid disease.
Makridis C; Theodorsson E; Akerström G; Oberg K; Knutson L
J Gastroenterol Hepatol; 1999 May; 14(5):500-7. PubMed ID: 10355517
[TBL] [Abstract][Full Text] [Related]
11. Measurement and partial characterization of the multiple forms of neurokinin A-like immunoreactivity in carcinoid tumours.
Conlon JM; Deacon CF; Richter G; Schmidt WE; Stöckmann F; Creutzfeldt W
Regul Pept; 1986 Jan; 13(2):183-96. PubMed ID: 3006157
[TBL] [Abstract][Full Text] [Related]
12. Neuropeptide K: a major tachykinin in plasma and tumor tissues from carcinoid patients.
Theodorsson-Norheim E; Norheim I; Oberg K; Brodin E; Lundberg JM; Tatemoto K; Lindgren PG
Biochem Biophys Res Commun; 1985 Aug; 131(1):77-83. PubMed ID: 2412557
[TBL] [Abstract][Full Text] [Related]
13. Tachykinin immunoreactivity in the parasitic flatworm Diclidophora merlangi and its fish host the whiting (Merlangius merlangus): radioimmunoassay and chromatographic characterisation using region-specific substance P and neurokinin A antisera.
Maule AG; Shaw C; Halton DW; Johnston CF; Fairweather I; Buchanan KD
Comp Biochem Physiol C Comp Pharmacol Toxicol; 1989; 94(2):533-41. PubMed ID: 2483928
[TBL] [Abstract][Full Text] [Related]
14. Neuropeptide K-(1-24)-peptide: storage and release by carcinoid tumors.
Conlon JM; Deacon CF; Grimelius L; Cedermark B; Murphy RF; Thim L; Creutzfeldt W
Peptides; 1988; 9(4):859-66. PubMed ID: 3226960
[TBL] [Abstract][Full Text] [Related]
15. In situ hybridization for detection of hormone and peptide mRNA in carcinoid tumors.
Funa K
Acta Oncol; 1991; 30(4):457-61. PubMed ID: 1854503
[TBL] [Abstract][Full Text] [Related]
16. Identification and characterization of multiple tachykinin immunoreactivities in bovine retina: evidence for the presence of a putative oxidative inactivation system for substance P.
Shaw C; Foy WL; Johnston CF; Buchanan KD
J Neurochem; 1989 Nov; 53(5):1547-54. PubMed ID: 2477501
[TBL] [Abstract][Full Text] [Related]
17. Chemical and immunochemical characterisation of substance P-like immunoreactivity and physalaemin-like immunoreactivity in a carcinoid tumour.
Conlon JM; Schäfer G; Schmidt WE; Lazarus LH; Becker HD; Creutzfeldt W
Regul Pept; 1985 Jun; 11(2):117-32. PubMed ID: 2412263
[TBL] [Abstract][Full Text] [Related]
18. Tachykinin production in granulomas of murine schistosomiasis mansoni.
Weinstock JV; Blum AM
J Immunol; 1989 May; 142(9):3256-61. PubMed ID: 2496164
[TBL] [Abstract][Full Text] [Related]
19. Tachykinins in carcinoid tumors: their use as a tumor marker and possible role in the carcinoid flush.
Norheim I; Theodorsson-Norheim E; Brodin E; Oberg K
J Clin Endocrinol Metab; 1986 Sep; 63(3):605-12. PubMed ID: 2426299
[TBL] [Abstract][Full Text] [Related]
20. The occurrence of pancreastatin in tumours of the diffuse neuroendocrine system.
Bishop AE; Bretherton-Watt D; Hamid QA; Fahey M; Shepherd N; Valentino K; Tatemoto K; Ghatei MA; Bloom SR; Polak JM
Mol Cell Probes; 1988 Sep; 2(3):225-35. PubMed ID: 2851738
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
